You May Like These Articles
How Medtech Companies Should Approach the Consumer Health Market: Interview with Movano CEO John Mastrototaro
Movano CEO John Mastrototaro talks about how medtech companies can build a successful consumer-facing brand while developing products that meet the needs of payers and providers.
How to Apply an Engineering Mindset to Your Medical Device Startup: Interview with Access Vascular CEO Jim Biggins
Access Vascular CEO Jim Biggins shares his strategies for developing a clinical research roadmap, creative commercialization models, and the reasons why clinician access is crucial for medtech entrepreneurs.
Glympse Bio CEO Caroline Loew discusses her “early-and-often” approach to dealing with regulatory issues and shares four things to consider ahead of conversations with potential investors.
Building Relationships, Raising Capital, and Establishing Reimbursement Codes: Interview with Oculogica CEO Rosina Samadani
Oculogica CEO Rosina Samadani on the importance of relationships in the regulatory and reimbursement processes, why first-time entrepreneurs shouldn’t be intimidated by complex procedures, and lessons learned from her experiences raising capital.
Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular
In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.
Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger
In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.
After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics
In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.
Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market
In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.
In this discussion with Matthew Amsden, learn about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.
How Remote Testing Can Change the Game for Patients and Clinicians: Interview with Katherine Ward of Healthy.io
In this conversation with Katherine Ward, we cover what Healthy.io does for the broader healthcare community, lessons from the COVID-19 crisis, and the value of decentralized remote diagnostic screening.
Is Off-Label Promotion Now Legal: What the Recent Criminal Case Against Vascular Solutions Means for Medtech
In this interview, Mark Duval discusses why the government's focus on speech vs. conduct is important when it comes to medical device off-label promotion.
In this interview with Dr. Mukesh Kumar, we learn about common misconceptions around the use of social media to market and sell FDA-regulated medical devices.